Generics Even as India-based drug majors Ranbaxy and Wockhardt reel under the impact of US Food and Drug Administration import bans on certain products, the drug regulator has issued another import alert, this time on Sun Pharmaceuticals' Karkhadi plant, in Gujarat, which saw its shares decline 6.5% on the news, reports The Pharma Letter’s India correspondent. 14 March 2014